Phosphodiesterase inhibitor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/47 (2006.01) A61K 31/496 (2006.01) A61K 31/5377 (2006.01) A61K 45/00 (2006.01) A61P 1/00 (2006.01) A61P 3/10 (2006.01) A61P 9/00 (2006.01) A61P 9/10 (2006.01) A61P 9/12 (2006.01) A61P 11/00 (2006.01) A61P 13/12 (2006.01) A61P 15/00 (2006.01) A61P 19/10 (2006.01) A61P 25/00 (2006.01) A61P 25/04 (2006.01) A61P 25/14 (2006.01) A61P 25/16 (2006.01) A61P 25/28 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) A61P 37/02 (2006.01) A61P 37/08 (2006.01) A61P 43/00 (2006.01) C07D 215/18 (2006.01) C07D 215/

Patent

CA 2493854

A phosphodiesterase 10A inhibitor which contains as an active ingredient a quinoline derivative represented by the following formula (I) or a pharmacologically acceptable salt of the derivative. (I) [In the formula, n is an integer of 1 to 4; R1 represents (un)substituted lower alkyl, -C(=Y)R9, etc.; R2 represents hydrogen, (un)substituted lower alkyl, etc.; R3 represents (un)substituted lower alkyl, (un)substituted aryl, (un)substituted heterocyclic group, etc.; and R4 represents halogeno, etc.]

L'invention concerne un inhibiteur de phosphodiestérase (10A) qui contient en tant que principe actif un dérivé de quinoline représenté par la formule (I), ou un sel de ce dérivé acceptable sur le plan pharmacologique. Dans la formule (I), n prend la valeur d'un entier compris entre 1 et 4; R?1¿ représente un alkyle inférieur (non) substitué, -C(=Y)R?9¿, etc.; R?2¿ représente un hydrogène, un alkyle inférieur (non) substitué, etc.; R?3¿ représente un alkyle inférieur (non) substitué, un aryle (non) substitué, un groupe hétérocyclique (non) substitué, etc.; et R?4¿ représente un halogéno, etc..

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Phosphodiesterase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphodiesterase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphodiesterase inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1676781

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.